![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual |
| Hypersensitivity Reaction |
|
Free Subscription
4 Allergy |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Hypersensitivity Reaction is free of charge.
Correspondence to 'Hypersensitivity Reactions to Human Albumin-A Case Series and
Diagnostic Algorithm'.
Allergy. 2025 Nov 27. doi: 10.1111/all.70168.
PubMed
Assessment of the Severity of Atopic Dermatitis Using Atomic Force Microscopy
Analysis of Skin Tape Strips.
Allergy. 2025 Nov 26. doi: 10.1111/all.70170.
PubMed
Major Cat Allergen Fel d 4: Structure and Identification of a Cross-Reactive
IgE-Epitope-Containing Area.
Allergy. 2025 Nov 24. doi: 10.1111/all.70146.
PubMed
Abstract available
Reply to Correspondence "Anaphylaxis Induced by Goat's and Sheep's Milk-A Rare
Entity in Europe".
Allergy. 2025 Nov 24. doi: 10.1111/all.70158.
PubMed
"Getting in and doing it personally": Engagement Strategies for Rural School
Asthma Programs.
Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00377.
PubMed
Abstract available
From the pages of AllergyWatch.
Ann Allergy Asthma Immunol. 2025;135:714-715.
PubMed
From breast to bite: Nutritional management in infantile food protein-induced
enterocolitis syndrome (FPIES).
Ann Allergy Asthma Immunol. 2025;135:626-633.
PubMed
Abstract available
The evolution of food protein-induced enterocolitis syndrome (FPIES): Global
trends, emerging triggers, and natural history.
Ann Allergy Asthma Immunol. 2025;135:616-625.
PubMed
Abstract available
Comparative analysis of biologics' effects on lung function parameters in severe
asthma.
Ann Allergy Asthma Immunol. 2025 Sep 6:S1081-1206(25)01156.
PubMed
Abstract available
Real-life evaluation of novel forced expiratory ratios with asthma exacerbations
and symptoms.
Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
PubMed
Abstract available
Ultrarush protocol safety and efficacy in Hymenoptera venom immunotherapy.
Ann Allergy Asthma Immunol. 2025;135:676-680.
PubMed
Abstract available
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12
years: APeX-P interim results.
Ann Allergy Asthma Immunol. 2025;135:681-688.
PubMed
Abstract available
Retrospective descriptive and analytical study of trends in the clinical and
allergenic profiles of atopic children in a Mediterranean Country (1992-2022).
Arch Pediatr. 2025 Nov 24:S0929-693X(25)00215.
PubMed
Abstract available
Exploring the indicative role of ACT score in improving lung function in
asthmatic children undergoing dust mite immunotherapy.
BMC Pediatr. 2025;25:951.
PubMed
Abstract available
Evaluation of the relationship between lung ultrasound findings and degree of
obstruction in newly diagnosed pediatric asthma patients.
BMC Pediatr. 2025;25:959.
PubMed
Abstract available
GPs must add extra checks after patient dies from penicillin allergy mix-up.
BMJ. 2025;391:r2513.
PubMed
Multimorbidity and Atopic Dermatitis in a Population-Based Cohort:
Severity-Dependent Association With Distinct Non-Atopic Multimorbidity Patterns.
Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093.
PubMed
Abstract available
Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in
children aged 6-11 years with moderate-to-severe atopic dermatitis: An
open-label, single-arm phase 1b/2a trial.
Br J Dermatol. 2025 Nov 24:ljaf455. doi: 10.1093.
PubMed
Abstract available
Analysis of skin aging patterns using a facial imaging system in atopic
dermatitis patients of 20-34 years old.
Eur J Dermatol. 2025;35:424-426.
PubMed
Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab
or Cyclosporine A: A Descriptive Case Series.
J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
PubMed
Abstract available
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe
atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind,
placebo-controlled, randomised phase 3 clinical trials.
Lancet. 2025 Nov 25:S0140-6736(25)01865-3. doi: 10.1016/S0140-6736(25)01865.
PubMed
Abstract available
Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.
Lancet. 2025 Nov 25:S0140-6736(25)02152-X. doi: 10.1016/S0140-6736(25)02152.
PubMed
Non-coeliac gluten sensitivity.
Lancet. 2025;406:2494-2508.
PubMed
Abstract available
inverted question markQue es la dermatitis atopica?
Pediatr Dermatol. 2025;42:E1-E2.
PubMed
What is atopic dermatitis?
Pediatr Dermatol. 2025;42:1270-1271.
PubMed
Abstract available
Thank you for your interest in scientific medicine.